Douglas J. Warner
Chief Medical Officer · Tyra Biosciences, Inc.
Individual
- 2025
- May 7, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Douglas J. Warner files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- Robert J. More - $5.25M in TYRA purchases and sales in the last 12 months
- Daniel Bensen - $4.81M in TYRA purchases and sales in the last 12 months
- Gilla Kaplan - $529K in TYRA purchases and sales in the last 12 months
- Rehan Verjee - $20K in TYRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Douglas J. Warner?
Douglas J. Warner is a corporate insider, tracked as Chief Medical Officer of Tyra Biosciences, Inc. (TYRA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Douglas J. Warner last file a Form 4?
The most recent primary Form 4 on record is dated 7 May 2026, one of 2 filings going back to 2025.
